
Viridian Therapeutics Inc
NASDAQ:VRDN

Viridian Therapeutics Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
11.02
25.71
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Viridian Therapeutics Inc hold over its rivals?
What risks and challenges
does Viridian Therapeutics Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Viridian Therapeutics Inc.
Provide an overview of the primary business activities
of Viridian Therapeutics Inc.
What unique competitive advantages
does Viridian Therapeutics Inc hold over its rivals?
What risks and challenges
does Viridian Therapeutics Inc face in the near future?
Has there been any significant insider trading activity
in Viridian Therapeutics Inc recently?
Summarize the latest earnings call
of Viridian Therapeutics Inc.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Viridian Therapeutics Inc.
Provide P/S
for Viridian Therapeutics Inc.
Provide P/E
for Viridian Therapeutics Inc.
Provide P/OCF
for Viridian Therapeutics Inc.
Provide P/FCFE
for Viridian Therapeutics Inc.
Provide P/B
for Viridian Therapeutics Inc.
Provide EV/S
for Viridian Therapeutics Inc.
Provide EV/GP
for Viridian Therapeutics Inc.
Provide EV/EBITDA
for Viridian Therapeutics Inc.
Provide EV/EBIT
for Viridian Therapeutics Inc.
Provide EV/OCF
for Viridian Therapeutics Inc.
Provide EV/FCFF
for Viridian Therapeutics Inc.
Provide EV/IC
for Viridian Therapeutics Inc.
Show me price targets
for Viridian Therapeutics Inc made by professional analysts.
What are the Revenue projections
for Viridian Therapeutics Inc?
How accurate were the past Revenue estimates
for Viridian Therapeutics Inc?
What are the Net Income projections
for Viridian Therapeutics Inc?
How accurate were the past Net Income estimates
for Viridian Therapeutics Inc?
What are the EPS projections
for Viridian Therapeutics Inc?
How accurate were the past EPS estimates
for Viridian Therapeutics Inc?
What are the EBIT projections
for Viridian Therapeutics Inc?
How accurate were the past EBIT estimates
for Viridian Therapeutics Inc?
Compare the revenue forecasts
for Viridian Therapeutics Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Viridian Therapeutics Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Viridian Therapeutics Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Viridian Therapeutics Inc compared to its peers.
Compare the P/E ratios
of Viridian Therapeutics Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Viridian Therapeutics Inc with its peers.
Analyze the financial leverage
of Viridian Therapeutics Inc compared to its main competitors.
Show all profitability ratios
for Viridian Therapeutics Inc.
Provide ROE
for Viridian Therapeutics Inc.
Provide ROA
for Viridian Therapeutics Inc.
Provide ROIC
for Viridian Therapeutics Inc.
Provide ROCE
for Viridian Therapeutics Inc.
Provide Gross Margin
for Viridian Therapeutics Inc.
Provide Operating Margin
for Viridian Therapeutics Inc.
Provide Net Margin
for Viridian Therapeutics Inc.
Provide FCF Margin
for Viridian Therapeutics Inc.
Show all solvency ratios
for Viridian Therapeutics Inc.
Provide D/E Ratio
for Viridian Therapeutics Inc.
Provide D/A Ratio
for Viridian Therapeutics Inc.
Provide Interest Coverage Ratio
for Viridian Therapeutics Inc.
Provide Altman Z-Score Ratio
for Viridian Therapeutics Inc.
Provide Quick Ratio
for Viridian Therapeutics Inc.
Provide Current Ratio
for Viridian Therapeutics Inc.
Provide Cash Ratio
for Viridian Therapeutics Inc.
What is the historical Revenue growth
over the last 5 years for Viridian Therapeutics Inc?
What is the historical Net Income growth
over the last 5 years for Viridian Therapeutics Inc?
What is the current Free Cash Flow
of Viridian Therapeutics Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Viridian Therapeutics Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Viridian Therapeutics Inc
NASDAQ:VRDN
|
1.2B USD | -1.6 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -195 865.9 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
322B USD | 14.8 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
149B USD | 13.7 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
137.8B USD | 10 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.4B USD | 24.3 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -576.8 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
113.5B AUD | 16.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
56.4B USD | 11.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -66.1 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
42.1B USD | -699.8 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Viridian Therapeutics Inc
NASDAQ:VRDN
|
Average EV/EBITDA:
15.1
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -195 865.9 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
14.8
|
13%
|
1.1 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
13.7
|
17%
|
0.8 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
10
|
6%
|
1.7 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
24.3
|
17%
|
1.4 |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -576.8 | N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
16.7
|
11%
|
1.5 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
11.1
|
11%
|
1 |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -66.1 | N/A | N/A |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Negative Multiple: -699.8 | N/A | N/A |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.